Thymus Extract - Mayzent (Siponimod) Interaction

Interaction Details

Siponimod is classified as belonging to the following category: Immunosuppressants

Theoretically, patients taking immunosuppressants may be at an increased risk of infection from contaminated thymus extract.
Thymus extract is derived from raw bovine thymus glands and is at risk for contamination. Tell patients to avoid thymus extract products unless these products are certified as pathogen-free.

Interaction Rating

Likelihood of Occurrence

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists

References

• Lewis CJ. Letter to reiterate certain public health and safety concerns to firms manufacturing or importing dietary supplements that contain specific bovine tissues. FDA. Available at: www.cfsan.fda.gov/~dms/dspltr05.html.

Siponimod Overview

• Siponimod is used to prevent episodes of symptoms and slow the worsening of disability in adults with relapsing-remitting forms (course of disease where symptoms flare up from time to time) of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control). Siponimod is in a class of medications called sphingosine l-phosphate receptor modulators. It works by decreasing the action of immune cells that may cause nerve damage.

Thymus Extract - More Interactions

Thymus Extract interacts with 112 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.